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Human adenoviruses (HAdVs) are partitioned into seven species,
based on characteristics including biochemical and genome proper-
ties and homologies, tissue tropism, and immunochemical examina-
tion of serum neutralizing and hemagglutinating epitopes that
are found on the virion capsid proteins. Species A contains three
members, HAdV-A12, -A18 and -A31, that generated earlier interest
due to their oncogenic capabilities, with HAdV-A12 and -A18 shown
to cause tumors in newborn hamsters (Huebner et al., 1962; Trentin
et al., 1962) and mice (Yabe et al., 1964). The precise basis for this
oncogenesis remains unknown; however, the HAdV-A12 E1A proteins
have been shown to repress class I major histocompatibility complex
expression in transformed rodent cells, and these E1A proteins
modulate class I gene expression by similar mechanisms in both
transformed rodent and human cells (Vasavada et al., 1986). Having
the complete genomes of HAdV-A18 and -A31 (Hofmayer et al., 2009)
allows additional detailed analyses by researchers.
HAdV-A18 was originally isolated from an anal swab of a child
with Niemann–Pick syndrome and characterized in the 1950s (Rowe
et al., 1956, 1958). Its role in human health is not well characterized;
however, another species A member, HAdV-A31, isolated originally
from the stool of a healthy child (Pereira et al., 1965), has been shownto be causative agents in gastrointestinal disease with the identiﬁca-
tion of subsequent ﬁeld isolates (Adrian and Wigand, 1989; Adrian et
al., 1987; Brown et al., 1984; Hammond et al., 1985; Kidd et al., 1982).
Several other HAdV species are associatedwith gastroenteritis and are
isolated from stool samples as well. Among these, the members of
species F (de Jong et al., 1983; Uhnoo et al., 1984) are of particular
importance because they are the genomes most closely similar to
those from species A, as reported in the phylogenetic and percent
identity data of this report. The association of HAdV-A31 with
gastroenteritis, its genome identity with HAdV-A18, and the close
relationship between the HAdV-F and HAdV-A species all suggest a
potential pathogenic role as a gastroenteritis agent for HAdV-A18.
Reports of HAdV coinfections (Vora et al., 2006), coupled with the
isolation of HAdV mixtures and HAdV types (De Jong et al., 1999) from
immunocompromised individuals suggest the possibility of the host
acting as a bioreactor, and this provides amolecular pathway for HAdV-
type evolution and pathogen emergence by recombination. Novel types
of HAdV, isolated as emergent pathogens causing highly contagious
outbreaks, have been reported recently. These have been characterized
using a genomics and bioinformatics approach to take advantage of the
high-resolution methodologies (Ishiko and Aoki, 2009; Walsh et al.,
2009; Yang et al., 2009). The pathogens include a respiratory, HAdV-B55
(Yang et al., 2009), three ocular pathogens, HAdV-D53 and -D54, and a
reanalysis of HAdV-D22 (Ishiko and Aoki, 2009; Robinson et al., 2009;
Walsh et al., 2009). Reexamination of several prototype strains of HAdV
respiratory pathogens archived at the American Type Culture Collection
(ATCC; Manassas, VA) by genome sequencing and bioinformatic
analysis shows a role of recombination in their genesis (HAdV-E4,
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HAdV-B16, manuscript in preparation). However, currently there are
limited numbers of whole HAdV genome sequences available in
GenBank, handicapping a full comprehensive genomic analysis, partic-
ularly of recombination events. In several recombination analysis pro-
ﬁles ofHAdV-A18, a suggestion of recombination is present, but the data
are inconclusive perhaps lacking the appropriate genome sequence(s)
for comparison. An example of this problem is demonstrated in the
recently characterized emergent keratoconjuntivitis pathogen, HAdV-
D53, in which a span of recombinant sequences showed similarity to an
unsequenced and/or unknown HAdV genome. This reﬂects also the
recent applications of these tools to the HAdV genomes, as well as the
limited number of genomes archived.
To support and enhance continuing computational and compar-
ative studies on the molecular evolution and pathoepidemiology of
HAdV, the genome and analysis of HAdV-A18 is presented. Reex-
amining the oncogenesis data reported for species A genomes in the
context of these newer genome data will allow further understanding
of the biology of these rarely reported HAdVs.
Results and discussion
Genome
There are three members of the HAdV-A species, originally dif-
ferentiated by serum neutralization and clustered with respect to
biological and genome-derived similarities. All are now sequenced,
annotated, and analyzed. SmaI in silico restriction enzyme digest
patterns are consistent with previously reported data, with additional
small-sized bands visible (data not shown; Wadell et al., 1980). The
genome of HAdV-A18 has a length of 34,177 nucleotides compared to
34,125 for HAdV-A12 and 33,763 for HAdV-A31. The GC content, of
46.5%, is consistent with species A, even though the three genomes in
this species provide a small sample size for such an analysis. Percent
GC is a metric for species identiﬁcation. This and the percent of
identity of HAdV-A18 relative to representative HAdVs are noted in
Table 1.
An overview of other HAdV species, particularly those with more
members, validates grouping by this metric (data not shown). Species
A genomes have been noted as being the most diverse within species
groupings than the other species. Still, HAdV-A18 shows the highest
genome nucleotide identity to the other HAdV-A members (83% to
HAdV-A12 and 80.5% to HAdV-A31) than to other HAdV prototypes.
For example, lower levels of genome identities are observed in
comparison with genomes from other species with HAdV-F40 and -
F41 having the next highest values of identity to HAdV-A18 (61.1%).Table 1
GC content and percent identity of HAdV-A18, relative to representative HAdVs.
HAdV Accession no. % Identity % GC
HAdV-A18 GU191019 100.0 46.5
HAdV-A12 AC_000005 83.0 46.5
HAdV-A31 In press 80.5 46.4
HAdV-B3 AY599834 60.3 51.1
HAdV-B7 AY594255 60.5 51.0
HAdV-B11 AY163756 60.6 48.9
HAdV-B14 AY803294 60.6 48.1
HAdV-C2 AC_000007 58.7 55.2
HAdV-C5 AC_000008 58.7 55.2
HAdV-D9 AJ854486 57.0 57.1
HAdV-D53 FJ169625 56.6 56.2
HAdV-E4 AY594253 58.3 57.7
SAdV-E25 AC_000011 58.5 59.8
HAdV-F40 NC_001454 61.1 51.2
HAdV-F41 DQ315364 61.1 51.0
SAdV-G1 NC_006879 58.8 55.2
HAdV-G52 DQ923122 58.4 55.1Species A members have been implicated in tumor formation in
rodents, initially observed for HAdV-A12 (Huebner et al., 1962). It has
also been observed that transformation of cells in vitro by HAdV-A12
requires both E1A and E1B genes based on restriction enzyme
digestion products (Graham et al., 1974). These low-resolution
studies though “state-of-the-art at the time, i.e., using restriction
enzyme fragments, can be reinterpreted given the whole genome
data. HAdV-A12 was one of the ﬁrst HAdV genomes sequenced,
archived as X73487 (Sprengel et al., 1994). Its genome has been
reannotated as AC_000006 and has been useful as a reference genome
for ongoing HAdV research. The two remaining species A members
were recently sequenced and shown to contain sequences in common
with those from HAdV-A12 but are still distinctly different. Signiﬁ-
cantly, the sequences that constitute the “transforming segment”,
originally deﬁned as a restriction enzyme fragment comprising the
left 7.2% of the genome, have a high level of similarity with each other,
ca. 80%. This similarity is not present in other HAdVs, for example in
neither HAdV-B7 nor in HAdV-C2 and -C5 (Fujinaga et al., 1977;
Sawada et al., 1979), which were discussed in the literature as not
hybridizing to the HAdV-A12 counterpart; these show less than 61%
identity (61%, 58.66%, and 59.8%, respectively).
Analysis of selected genes
Selected and presumably important and differentiating nucleotide
coding sequences from HAdV-A18 were chosen for further analysis
and comparison to homologs from other HAdV species from the
preliminary computational analysis of all coding sequences. These
selected coding sequences include E1A, DNA polymerase (Pol),
penton, hexon, ﬁber, and E4 34 kDa. The penton, hexon, and ﬁber
genes of HAdV are of particular importance because they are outer
coat proteins, which play a signiﬁcant role in the tropism of the virus,
as well as in the deﬁnition and identiﬁcation of these prototypes
based on serum neutralization and hemagglutination epitopes. E1A,
Pol, and E4 34 kDa were added to this analysis to provide a more
complete picture of HAdV-A18, across the genome from its proximal
to distal ends. The Pol sequence is important as a conserved essential
gene, while the E1A protein has been implicated as a determinant of
the tumorigenic properties of these HAdVs. Whole genome sequences
are included in the analysis as a further reference.
Alignments and percent identities
Multiple sequence alignments provide a more detailed under-
standing of the genes relative to other HAdVs. The nucleotide coding
sequences of HAdV-A18 selected genes were analyzed with respect to
percent identities and are presented in comparison with homologs
found in other HAdVs (Fig. 1).
The percent identity values for the selected coding sequences
follow a pattern similar to that of the identity values noted (Table 1)
for the HAdV whole genome. HAdV-A18 shows the highest identity
relationship to the other HAdV-A serotypes, with lower identity
values observed for other species. HAdV-A18 shows the highest
identity to HAdV-A12 in most of the coding sequences presented.
However, the hexon and E4 34 kDa genes of HAdV-A18 are more
similar to homologs in HAdV-A31. This type of pattern suggests the
possibility of a recombination event in one or both of these genes. The
genome of HAdV-A18 was examined for recombination events (data
described later in this report) and none were found.
Phylogenetic relationships of selected genes
Phylogenetic trees were used to explore the relationship of the
coding sequences of HAdV-A18 to homologs in other HAdV species
(Fig. 2). Members of the same species form distinct clades in all of the
trees. In every tree except the hexon, members of the HAdV-A species
Fig. 1. Dot plot analysis of percent identity of selected genes. The percent identities of
selected genes of HAdV-A18, to homologs in other species, are presented in the form of
a dot plot. Twomembers of each species (A, B1, B2, C, D, E, F, and G) were chosen for the
analysis to provide range and completeness. The resulting values were grouped by gene
and sorted in descending order according to the median percent identity values of the
genes. Values in each gene panel are grouped by species and sorted according to
descending median percent identity. The chart was constructed using the R statistical
computing environment (http://www.R-project.org/).
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together, and HAdV-A18 pairing alone within the species A clade.
However, in the hexon tree HAdV-A31 subclades with HAdV-A18
rather than HAdV-A12. This change in pattern among the phyloge-
netic trees is suggestive of a possible recombination event between
the hexon sequences of HAdV-A18 and -A31.
Hexon recombination analysis
Patterns observed in percent identity values and phylogenetic
trees for the coding sequences of HAdV-A18 suggest a possible
recombination event with the hexon of HAdV-A31. To explore this
observation further, analyses with Bootscan and Simplot (Lole et al.,
1999) software were conducted with the hexon of HAdV-A18 (Fig. 3).
Bootscan data show a possible recombination event. However, the
Bootscan results are not as clear-cut and conclusive as those used tosupport previously reported recombination events (Robinson et al.,
2009; Walsh et al., 2009). For example, in the previous cases
demonstrating recombination, peaks in the Bootscans showed long
stretches of values at 100%, indicating a strong close phylogenetic
relationship between the recombinant sequences. The HAdV-A18
Bootscan shows no such pattern, which suggests a weaker phyloge-
netic relationship or perhaps a more ancient one with genetic drift
contributing to and complicating this result. However, the Bootscan
analysis does show two distinct sets of peaks that indicate that the
ﬁrst half of the hexon of HAdV-A18 is closely related to HAdV-A31
while the second half is more related to HAdV-A12. This pattern is
common among the HAdV hexons that have been shown to contain a
recombination event. In contrast, Simplot and percent identity data
reveal that there is only 84.5% identity between the hexons of HAdV-
A18 and -A31. Recombinations in other HAdV genomes from the
literature have shown percent identity values of greater than 95%
(Walsh et al., 2009). Therefore, the sum of the data from these
analyses, e.g., Simplots, Bootscans, phylogenetic trees, and percent
identity values, suggests that if there is a recombination event
between the hexons of HAdV-A18 and -A31, it is either due to an
ancient event or it is to another “yet-to-be-sequenced”HAdV genome.
Other sequences
VA RNAs
The HAdV genomes contain coding sequences for one or two “virus
associated RNA” (VA RNA) sequences. These are transcribed by the
host RNA polymerase III (Gonçalves and de Vries, 2006) and are noted
to play a role in the inhibition of the host anti-viral functions
(Mathews and Shenk, 1991). The number of VA RNAs varies according
to species, with the genomes of HAdV species B2, C, D, and E encoding
for two VA RNAs (VA RNA I and VA RNA II) and the members of
species A, B1, F, and G encoding for a single VA RNA (VA RNA I).
Table 2 lists the lengths and percent identities of VA RNA I of
HAdV-A18 relative to its homolog from other HAdVs. VA RNA I of
HAdV-A18 has an identical length to its homolog in species A
members and shows the highest identity scores to the VA RNA I of
HAdV-A12. Among the non-HAdV-A species, HAdV-A18 shows the
highest identity to the VA RNA of HAdV-G52 (65.3%).
Inverted terminal repeats
Both ends of the HAdV genomes contain “Inverted Terminal
Repeat” (ITR) sequences (Dán et al., 2001; Hatﬁeld and Hearing,
1993). The ITRs are conserved and are crucial for the replication of the
virus as they contain the sequence motifs for DNA replication (Dán et
al., 2001; Hatﬁeld and Hearing, 1993; Temperley and Hay, 1992).
Three important components of the ITR are the canonical core origin
(Temperley and Hay, 1992), NF I binding site, and NF III binding site
(Hatﬁeld and Hearing, 1993). The core origin binds a pre-terminal
protein (pTP)-Pol heterodimer, and the NF I and NF III binding sites
interact with the host transcription factors, which are required for
adenovirus replication.
Fig. 4 shows a schematic representation of an alignment of the ITRs
of several HAdVs. The ITR of HAdV-A18 contains all of the requisite
components: a core origin and both NF I/NF III binding sites. However,
the core origin of HAdV-A18 contains mutations in its second and
third bases, “TA” to “AT”, not found elsewhere to date. This mutation
causes the core origin of HAdV-A18 to be unique among sequenced
HAdV ITRs, but its signiﬁcance and effects are undetermined. It has
been shown that the core origins of non-human adenoviruses are not
as well conserved, in contrast to the HAdVs, and observations from the
literature suggest that an “AT-rich” domain is all that is required for
the core origin to be functional (Dán et al., 2001). This indicates that
while this mutation is unique among the HAdVs, it may not have
noticeable effect on the replication of the virus. Alternatively, it may
Fig. 2. Phylogenetic relationships. A neighbor-joining algorithm was used to determine the phylogenetic relationships of the E1A, DNA polymerase, penton, hexon, ﬁber, and E4
34 kDa nucleotide coding sequences. For reference, a whole genome analysis is presented. Numbers next to the branches of the trees indicate the percentage of replicate trees in
which the associated taxa clustered together in the bootstrap test (1000 replicates).
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the non-human adenoviruses.
Proteome analysis
Examining the in silico proteome of HAdV-A18 can provide
information on the effects of the differences observed in nucleotide
alignments discussed earlier. To this end, the proteins of HAdV-A18
were aligned with their homologs in HAdV-A12 and -A31. Percent
identities, which were calculated based on these alignments, are
displayed in Fig. 5.Protein percent identities
The percent identity values show that the proteome of HAdV-A18
is most similar to that of HAdV-A12. Within the two proteomes, the
highest identity values are in the E4 ORF 3 protein and the least
similar values are in the CR1-α and CR1-β proteins.
Virtual 2D gel electrophoresis
To examine the differences in the proteomes of HAdV-A18, -A31,
and -A12, all sequence-based predicted proteins from the genomes
Fig. 3. Hexon recombination analysis. (Top) Bootscan and (bottom) Simplot recombination results are shown. The positions of the putative serotyping epitopes and the two
hypervariable loops, of the hexon, are noted above the graphs as reference. The parameters are listed in red or blue lettering under each.
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proteins based on their computed isoelectric point (pI) and molecular
weight. None of the homologs from the three genomes shows
signiﬁcant differences in molecular weight. However, some homologs
display charge differences. Selected proteins are noted and presented
in Fig. 6: the coat proteins that are putatively involved in tissue
tropism and serve as serum neutralization and hemagglutination
epitopes for laboratory serotyping; E1A protein, which is reported in
the literature as the transforming or tumorigenic factor; DNA poly-
merase, a conserved essential protein; and several E3 transcript-derived proteins, which are reported to be involved in host immune
system evasion. Of particular interest, the ﬁber and CR1-β proteins
show the greatest discrepancy in charge density and molecular size,
which is not unexpected given the low identity values of these
proteins to one another. The ﬁber protein provides recognition of host
cell surface proteins and provides entry into the cell, as a cell tropism
parameter. CR1-β is important as it is noted to have a role in escaping
the host immunosurveillance (Burgert and Blusch, 2000). Interest-
ingly, the RID-alpha proteins of HAdV-A18 and -A31 show very
similar charge/mass ratios in spite of the fact that they share only
Table 2
Comparison of VA RNA coding regions.
Length of VA RNA I VA RNA I Length of VA RNA II VA RNA II
HAdV-A12 141 97.2 – –
HAdV-A31 141 90.1 – –
HAdV-B3 175 52.5 177 50.4
HAdV-B7 175 52.5 171 52.5
HAdV-B11 158 53.2 – –
HAdV-B14 162 51.8 – –
HAdV-C2 160 48.9 158 54.6
HAdV-C5 160 48.9 158 54.6
HAdV-D9 163 58.9 154 47.5
HAdV-D53 163 58.2 179 47.5
HAdV-E4 159 58.2 101 33.7
SAdV-E25 159 56.0 160 46.8
HAdV-F40 171 63.1 – –
HAdV-F41 174 63.8 – –
HAdV-G52 164 65.3 – –
SAdV-G1 164 63.8 – –
Percent identities and coding lengths of VA RNA I from HAdV-A18, relative to
counterparts in other species.
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polypeptide analysis that the patterns are “clearly distinct from each
other” (Wadell et al., 1980). The hexon protein analysis, both 2D gel
and phylogeny, also support the past observation that these three
viruses cross-react via serum neutralization, while the phylogeny
analysis agrees with the observation of similar hemagglutination–Fig. 4. HAdV ITR analysis. An alignment of the ITRs of selected HAdV is presented, with criti
conserved nucleotides within the boxes appear as blue italics, with the Sp1 motif (GGGCGGinhibition assay results for these species Amembers; the 2D gel shows
physical differences between the three ﬁbers (Wadell et al., 1980).
Conclusion
This report of the HAdV-A18 genomic sequence data and analysis
completes the set of genomes classiﬁed within the HAdV-A species.
One of the major contributions of this HAdV-A18 genome sequence is
that it serves as a reference for further genomic and wet-bench
studies, both as a reference for recombination analysis in under-
standing the phylogeny andmolecular evolution and for studies of the
origins of HAdVs. It is also important for understanding the putative
roles of several HAdV genomes and their genes in reported and
potential oncogenesis in rodents; the exact nucleotide sequences will
allow additional wet-bench investigations.
Recombination has been implicated as a mechanism in the
emergence of HAdVs as pathogens (Walsh et al., 2009). HAdV-A18
was examined for recombination events, but no overwhelming
evidence of an event was found. However, as these types of in silico
analyses are novel, further and additional genome studies are
required to deﬁne the exact metrics for recombination. The few
recent HAdV recombination events reported in the literature to date
are very clearly supported by these data (Robinson et al., 2009; Walsh
et al., 2009). However, in the case of HAdV-A18, while the Bootscan
analysis evidence revealed the strong possibility of a recombination
event in the hexon with HAdV-A31, complementary Simplot analysis
and percent identity data are not supportive. Therefore, either thecal sequence motifs marked: core origin, NF I binding site, and NF III binding site. Non-
) underlined and ATF motif (TGACGT) boxed.
Fig. 5. Dot plot of protein percent identities. The percent identities of proteins of HAdV-A18 to homologs in the other members of the HAdV-A species (HAdV-A12 is in light blue
and-A31 is in dark red) are plotted in a dot plot format. The proteins are sorted according to the location of their nucleotide coding sequence. This chart was constructed using the
R statistical computing environment (http://www.R-project.org/).
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recombination event that is from an ancient event that has been
complicated by genetic drift. As more HAdV recombination events are
revealed and studied, the predicament of conﬂicting results between
phylogeny-based methods (Bootscan) and similarity-based methods
(Simplot and percent identity data) will likely to become a more
prominent problem.Fig. 6. Virtual 2D gel electrophoresis analysis. The in silicomigration patterns of select proteins
(blue or darker shade of gray) are noted, with arrows or boxes clustering the homologs.Materials and methods
HAdV-A18 was obtained from the collection at the Viral and
Rickettsial Disease Laboratory (VRDL; California Department of Public
Health), archived as TC-81190. The passage history of this stock is
given as follows: ﬁve times through HeLa cells and eight times
through KB cells at the National Institutes of Health, where the virusof HAdV-A18 (red and circled), HAdV-A12 (green or lighter shade of gray), and HAdV-A31
291M.P. Walsh et al. / Virology 404 (2010) 284–292was ﬁrst cultured; and followed by passage through HeLa cells twice
and human fetal diploid kidney cells four times at VRDL.
Preparation of HAdV-A18 for genome sequencing
For DNA production and collection, the HAdV-A18 stock was
passed once onto monolayers of A549 cells in 25-cm2 ﬂasks to verify
cytopathic effect, and then subsequently ampliﬁed in monolayers of
A549 cells in 75-cm2 ﬂasks for intracellular viral DNA extraction, using
a protocol described by Kajon and modiﬁed from Shinagawa (Kajon
and Erdman, 2007). Cells collected from this passage were concen-
trated two-fold, and viral DNA was extracted and further processed
using aMagnaNA Pure LC DNA Isolation Kit I (Roche; Indianapolis, IN),
in accordance to the manufacturers' instructions.
Ampliﬁcation and sequencing of the HAdV-A18 genome
To amplify regions of HAdV-A18, primers based on the conserved
adenovirus sequences of HAdV-A12were designed to ﬂank the known
sequences. All amplicons were sequenced using a primer-walking
strategy and the Sanger sequencing chemistry with ladders resolved
on an ABI3730x.
Sequence analysis and genome annotation
DNA sequence data were parsed and assembled using SeqMan
software (Lasergene 8, Madison, WI). In toto, the genome assembly
contained 1718 high-quality reads with an average length of 300 bps.
Nucleotide coverage for both strands of the genome was 8-fold.
The annotated sequence of HAdV-A18 has been deposited in
GenBank and is accessioned as GU191019. For the computational
analyses, the followingHAdVgenomeswere used:HAdV-A18 (reported
here), HAdV-A12 (AC_000005), HAdV-A31 (Heim, personal communi-
cation; AM749299), HAdV-B3 (AY599834), HAdV-B7 (AY594255),
HAdV-B11 (AY163756), HAdV-B14 (AY803294), HAdV-C2
(AC_000007), HAdV-C5 (AC_000008), HAdV-D9 (AJ854486), HAdV-
D53 (FJ169625),HAdV-E4 (AY594253), SAdV-E25 (AC_000011), HAdV-
F40 (NC_001454), HAdV-F41 (DQ315364), SAdV-G1 (NC_006879), and
HAdV-G52 (DQ923122).
Bioinformatic analyses were performed using protocols and net-
accessible software tools similar to those described in earlier
publications (Walsh et al., 2009; Seto et al., 2009): (1) MAFFT
(http://www.ebi.ac.uk/Tools/mafft/; Katoh et al., 2002) was used to
compute alignments of nucleotide sequences; (2) nucleotide percent
identities were calculated using the UCSF Chimera package (Pettersen
et al., 2004); (3) Artemis (Rutherford et al., 2000) was used to view,
annotate, and compare genomes; (4) percent identity values for
annotated proteins were calculated using a BioJava (Holland et al.,
2008) implementation of a Needleman–Wunsch algorithm; (5) whole
genomes were aligned using MEGA (Tamura et al., 2007); ( 6)
phylogenetic bootstrapped neighbor-joining trees (1000 replicates)
were constructed using MEGA4 (Tamura et al., 2007); (7) recombi-
nation analysis was performed using Simplot (Lole et al., 1999); and
(8) in silico proteome analyses were performed using an in-house
beta software tool to calculate percent identities and applying a
virtual 2D gel electrophoresis analysis to compare protein charge and
size (JVirGel software; http://www.jvirgel.de; Hiller et al., 2006).
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